Literature DB >> 901632

Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases.

E M van den Berg-Loonen, B J Dekker-Saeys, S G Meuwissen, L E Nijenhuis, C P Engelfriet.   

Abstract

Of 118 Dutch patients suffering from ankylosing spondylitis (AS) 81-4% were found to be positive for the HLA antigen B27. The B27 frequency proved to be significantly higher in patients in whom the disease had an early onset. In addition to B27, another HLA antigen may be associated with AS; the antigen Bw 16 was found to be significantly increased in B27 negative AS patients. HLA phenotype frequencies were also determined in 109 patients with idiopathic inflammatory bwel disease (IBD). In fifty-eight ulcerative colitis (UC) patients a raised incidence of A 11 was noticed. In fifty-one patients with Crohn's disease (CD) the antigen B18 showed an increased frequency. Both deviations were statistically significant. In thirty-nine patients suffering from both AS and IBD 50% proved to be B27 positive, which is significantly diffrent from B27 frequency in patients with AS alone. In the B27 negative patients with AS and IBD and increased frequency of Bw16 was also shown.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 901632     DOI: 10.1111/j.1744-313x.1977.tb00899.x

Source DB:  PubMed          Journal:  J Immunogenet        ISSN: 0305-1811


  10 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  An HLA study on 149 Japanese patients with Crohn's disease.

Authors:  H Matake; N Okabe; S Naito; T Yao
Journal:  Gastroenterol Jpn       Date:  1992-08

3.  Genetic considerations on association between HLA and disease.

Authors:  L E Nijenhuis
Journal:  Hum Genet       Date:  1977-09-22       Impact factor: 4.132

4.  Immunoglobulin allotypes in Crohn's disease in the Netherlands.

Authors:  I Biemond; G G de Lange; I T Weterman; A S Pena
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

5.  Linkage of inflammatory bowel disease to human chromosome 6p.

Authors:  J Hampe; S H Shaw; R Saiz; N Leysens; A Lantermann; S Mascheretti; N J Lynch; A J MacPherson; S Bridger; S van Deventer; P Stokkers; P Morin; M M Mirza; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

6.  Crohn's disease: the genetic contribution.

Authors:  J Sofaer
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

7.  A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

Authors:  J Hampe; S Schreiber; S H Shaw; K F Lau; S Bridger; A J Macpherson; L R Cardon; H Sakul; T J Harris; A Buckler; J Hall; P Stokkers; S J van Deventer; P Nürnberg; M M Mirza; J C Lee; J E Lennard-Jones; C G Mathew; M E Curran
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

8.  HLA B27 and the genetics of ankylosing spondylitis.

Authors:  J C Woodrow; C J Eastmond
Journal:  Ann Rheum Dis       Date:  1978-12       Impact factor: 19.103

9.  Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease.

Authors:  B J Dekker-Saeys; S G Meuwissen; E M Van Den Berg-Loonen; W H De Haas; K A Meijers; G N Tytgat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

10.  HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies.

Authors:  G Vargas-Alarcón; A Garcia; S Bahena; H Melin-Aldana; F Andrade; G Ibañez-de-Kasep; J Alcocer-Varela; D Alarcón-Segovia; J Granados
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.